Evidence map›Paper›PMID 41277827›Full record

ArticleInfection and immunity2025

Comparison of cytokine responses to group B

Leslie A Kirk, Hannah A Richards, Danyvid Olivares-Villagómez, Andrea Locke, Anthony R Flores, Shannon D Manning, David M Aronoff, Kevin G Osteen, David E Cliffel, Alison J Eastman and 1 more

Abstract readComparative Study
In one paragraph

Article in Infection and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Leslie A KirkDepartment of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Hannah A RichardsDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee, USA.
Danyvid Olivares-VillagómezDepartment of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Andrea LockeDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee, USA.
Anthony R FloresDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-6402-4269
Shannon D ManningDepartment of Microbiology, Genetics, and Immunology, Michigan State University, East Lansing, Michigan, USA.ORCID 0000-0001-9581-0660
David M AronoffDepartment of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Kevin G OsteenDepartment of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
David E CliffelDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee, USA.
Alison J Eastman *Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-4296-2916
Jennifer A Gaddy *Department of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-2192-4224

Funding

TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007028 · NIEHS · VANDERBILT UNIVERSITY · PI F PETER Guengerich, Fiona Edith Harrison · 1985 to 2026
$15.7M
Instrumenting the Fetal Membrane on a ChipR01HD102752 · NICHD · VANDERBILT UNIVERSITY · PI CLIFFEL, DAVID E · 2020 to 2023
$2.5M
Utility of human milk oligosaccharides against the perinatal pathogen, Group B StreptococcusR01HD113675 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jennifer A Gaddy, Steven D. Townsend · 2024 to 2026
$1.1M
BLRD VA I01 BX005352Burroughs Wellcome Fund 1275387Department of Veterans Affairs Office of Research Merit Review Award I01BX005352-01March of Dimes Foundation 6-FY24-0009NICHD NIH HHS R01 HD102752NICHD NIH HHS R01 HD113675NIEHS NIH HHS T32 ES007028NIH HHS 1R01HD113675NIH HHS R01HD102752NIH HHS T32 ES007028
6 · The paper itself

Abstract

Adverse pregnancy outcomes represent a global health burden. Bacterial infection and subsequent inflammation in gestational membranes lead to immunological and physiological changes that contribute to adverse pregnancy outcomes. Although animal models of infection during pregnancy are useful to interrogate tissue and cellular level changes in host responses, these models also have numerous drawbacks, including cost, complexity, and ethical considerations. The advent of organ-on-a-chip models provides cutting-edge new approaches to model host-pathogen interactions in multicellular organ and tissue environments. In this work, we employ an organ-on-a-chip model of the maternal-fetal interface as a tool to study immunological responses to infection with the perinatal pathogen, Group B

Indexed as

CytokinesExtraembryonic MembranesLab-On-A-Chip DevicesPregnancy Complications, InfectiousStreptococcal InfectionsStreptococcus agalactiaeFemaleHost-Pathogen InteractionsHumansMicrophysiological SystemsPregnancyCytokinesbacteriagestational membranespregnancyreproductive immunologyStreptococcus

Identifiers

PMID41277827
PMCPMC12707140

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.